These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25960181)

  • 1. A proteomic approach to obesity and type 2 diabetes.
    López-Villar E; Martos-Moreno GÁ; Chowen JA; Okada S; Kopchick JJ; Argente J
    J Cell Mol Med; 2015 Jul; 19(7):1455-70. PubMed ID: 25960181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic study of skeletal muscle in obesity and type 2 diabetes: progress and potential.
    Kruse R; Højlund K
    Expert Rev Proteomics; 2018 Oct; 15(10):817-828. PubMed ID: 30251560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential proteome analysis of diabetes mellitus type 2 and its pathophysiological complications.
    Sohail W; Majeed F; Afroz A
    Diabetes Metab Syndr; 2018 Nov; 12(6):1125-1131. PubMed ID: 29907545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in proteomic studies of adipose tissues and adipocytes.
    Kim EY; Kim WK; Oh KJ; Han BS; Lee SC; Bae KH
    Int J Mol Sci; 2015 Feb; 16(3):4581-99. PubMed ID: 25734986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome-wide alterations on adipose tissue from obese patients as age-, diabetes- and gender-specific hallmarks.
    Gómez-Serrano M; Camafeita E; García-Santos E; López JA; Rubio MA; Sánchez-Pernaute A; Torres A; Vázquez J; Peral B
    Sci Rep; 2016 May; 6():25756. PubMed ID: 27160966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary proteomics in biomedical research.
    Zhang A; Sun H; Wang P; Wang X
    Clin Chim Acta; 2013 Jan; 415():261-5. PubMed ID: 23146870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications.
    Wang N; Zhu F; Chen L; Chen K
    Life Sci; 2018 Nov; 212():194-202. PubMed ID: 30243649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics of ovarian cancer: functional insights and clinical applications.
    Elzek MA; Rodland KD
    Cancer Metastasis Rev; 2015 Mar; 34(1):83-96. PubMed ID: 25736266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic identification of salivary biomarkers of type-2 diabetes.
    Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
    J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The trend in application of omics in type 2 diabetes researches; A bibliometric study.
    Hosseinkhani S; Aazami H; Hashemi E; Dehghanbanadaki H; Adibi-Motlagh B; Razi F
    Diabetes Metab Syndr; 2021; 15(5):102250. PubMed ID: 34419857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics biomarkers for non-small cell lung cancer.
    Kisluk J; Ciborowski M; Niemira M; Kretowski A; Niklinski J
    J Pharm Biomed Anal; 2014 Dec; 101():40-9. PubMed ID: 25175018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic and bioinformatic analysis of membrane proteome in type 2 diabetic mouse liver.
    Kim GH; Park EC; Yun SH; Hong Y; Lee DG; Shin EY; Jung J; Kim YH; Lee KB; Jang IS; Lee ZW; Chung YH; Choi JS; Cheong C; Kim S; Kim SI
    Proteomics; 2013 Apr; 13(7):1164-79. PubMed ID: 23349036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic identification of human urinary biomarkers in diabetes mellitus type 2.
    Riaz S; Alam SS; Srai SK; Skinner V; Riaz A; Akhtar MW
    Diabetes Technol Ther; 2010 Dec; 12(12):979-88. PubMed ID: 20735160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of visceral adipose tissue in pre-obese patients with type 2 diabetes.
    Murri M; Insenser M; Bernal-Lopez MR; Perez-Martinez P; Escobar-Morreale HF; Tinahones FJ
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):99-106. PubMed ID: 23791845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Current Diabetes Proteomics: From the Perspectives of Label- free Quantification and Biomarker Selection.
    Fu J; Luo Y; Mou M; Zhang H; Tang J; Wang Y; Zhu F
    Curr Drug Targets; 2020; 21(1):34-54. PubMed ID: 31433754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network-Based Association Study of Obesity and Type 2 Diabetes with Gene Expression Profiles.
    Zhang S; Wang B; Shi J; Li J
    Biomed Res Int; 2015; 2015():619730. PubMed ID: 26273637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic identification of biomarkers of skeletal muscle disorders.
    Ohlendieck K
    Biomark Med; 2013 Feb; 7(1):169-86. PubMed ID: 23387498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker discovery in asthma and COPD by proteomic approaches.
    Rossi R; De Palma A; Benazzi L; Riccio AM; Canonica GW; Mauri P
    Proteomics Clin Appl; 2014 Dec; 8(11-12):901-15. PubMed ID: 25186471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Saliva Collection Devices for Proteomics: An Update.
    Khurshid Z; Zohaib S; Najeeb S; Zafar MS; Slowey PD; Almas K
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying new Risk Markers and Potential Targets: The Value of the Proteome.
    Kontush A
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):13-8. PubMed ID: 26931819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.